BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 28759388)

  • 21. Integrated proteo-genomic approach for early diagnosis and prognosis of cancer.
    Shukla HD; Mahmood J; Vujaskovic Z
    Cancer Lett; 2015 Dec; 369(1):28-36. PubMed ID: 26276717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Computational Analysis of Specific MicroRNA Biomarkers for Noninvasive Early Cancer Detection.
    Song T; Liang Y; Cao Z; Du W; Li Y
    Biomed Res Int; 2017; 2017():4680650. PubMed ID: 28357401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Universal Genomic Testing Needed to Win the War Against Cancer: Genomics IS the Diagnosis.
    Subbiah V; Kurzrock R
    JAMA Oncol; 2016 Jun; 2(6):719-20. PubMed ID: 27078832
    [No Abstract]   [Full Text] [Related]  

  • 24. Noncoding RNAs in molecular characterization of cancer preneoplasia.
    Wang W; Srivastava S
    Cancer Biomark; 2010; 9(1-6):133-40. PubMed ID: 22112473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo functional screening for systems-level integrative cancer genomics.
    Weber J; Braun CJ; Saur D; Rad R
    Nat Rev Cancer; 2020 Oct; 20(10):573-593. PubMed ID: 32636489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.
    Kern R; Correa SC; Scandolara TB; Carla da Silva J; Pires BR; Panis C
    Per Med; 2020 Sep; 17(5):399-420. PubMed ID: 32804054
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted Transcriptional Profiling of Microdissected Biopsy Specimens Representing Early Colonic Neoplasia.
    Mo A; Jackson S; Devers TJ; Rosenberg DW
    J Cell Biochem; 2016 Dec; 117(12):2677-2681. PubMed ID: 27357168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early detection: the impact of genomics.
    van Lanschot MCJ; Bosch LJW; de Wit M; Carvalho B; Meijer GA
    Virchows Arch; 2017 Aug; 471(2):165-173. PubMed ID: 28573511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibodies as diagnostic and prognostic cancer biomarker: Detection techniques and approaches.
    Yadav S; Kashaninejad N; Masud MK; Yamauchi Y; Nguyen NT; Shiddiky MJA
    Biosens Bioelectron; 2019 Aug; 139():111315. PubMed ID: 31132724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
    Vogelzang NJ; Benowitz SI; Adams S; Aghajanian C; Chang SM; Dreyer ZE; Janne PA; Ko AH; Masters GA; Odenike O; Patel JD; Roth BJ; Samlowski WE; Seidman AD; Tap WD; Temel JS; Von Roenn JH; Kris MG
    J Clin Oncol; 2012 Jan; 30(1):88-109. PubMed ID: 22147736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moving Immunoprevention Beyond Virally Mediated Malignancies: Do We Need to Link It to Early Detection?
    Dhodapkar MV; Dhodapkar KM
    Front Immunol; 2019; 10():2385. PubMed ID: 31649683
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The path to routine use of genomic biomarkers in the cancer clinic.
    Boutros PC
    Genome Res; 2015 Oct; 25(10):1508-13. PubMed ID: 26430161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biomarkers: Portents of malignancy.
    Brower V
    Nature; 2011 Mar; 471(7339):S19-21. PubMed ID: 21430715
    [No Abstract]   [Full Text] [Related]  

  • 35. New perspectives on screening and early detection of endometrial cancer.
    Costas L; Frias-Gomez J; Guardiola M; Benavente Y; Pineda M; Pavón MÁ; Martínez JM; Climent M; Barahona M; Canet J; Paytubi S; Salinas M; Palomero L; Bianchi I; Reventós J; Capellà G; Diaz M; Vidal A; Piulats JM; Aytés Á; Ponce J; Brunet J; Bosch FX; Matias-Guiu X; Alemany L; de Sanjosé S;
    Int J Cancer; 2019 Dec; 145(12):3194-3206. PubMed ID: 31199503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health psychology and translational genomic research: bringing innovation to cancer-related behavioral interventions.
    McBride CM; Birmingham WC; Kinney AY
    Am Psychol; 2015; 70(2):91-104. PubMed ID: 25730717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular and cellular biology of pre-malignancy in the gastrointestinal tract.
    Jass JR; Talbot IC
    Best Pract Res Clin Gastroenterol; 2001 Apr; 15(2):175-89. PubMed ID: 11355910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early detection: Spotting the first signs.
    Savage N
    Nature; 2011 Mar; 471(7339):S14-5. PubMed ID: 21430712
    [No Abstract]   [Full Text] [Related]  

  • 39. The promise of omics-based approaches to cancer prevention.
    Meerzaman D; Dunn BK; Lee M; Chen Q; Yan C; Ross S
    Semin Oncol; 2016 Feb; 43(1):36-48. PubMed ID: 26970123
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TIME for Bugs: The Immune Microenvironment and Microbes in Precancer.
    Borthwick Bowen M; Helmink BA; Wargo JA; Yates MS
    Cancer Prev Res (Phila); 2023 Sep; 16(9):497-505. PubMed ID: 37428011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.